ÖZET
Amaç:
Obstrüktif uyku apne sendromu (OUAS), yaygın görülen uyku ile ilişkili bir solunum bozukluğudur. Sürekli pozitif hava yolu basıncı (CPAP) tedavisi, OUAS’nin en etkili tedavisi olmakla birlikte, psikolojik semptomlar ve diğer uyku bozuklukları varlığında CPAP tedavisine uyumda güçlükler yaşanabilmektedir. Biz de çalışmamızda, Koronavirüs hastalığı-2019 (COVID-19) pandemisi ve normalleşme sürecinde OUAS hastalarının cihaz uyumluluğunda salgın öncesi döneme göre farklılık olup olmadığını araştırmayı amaçladık.
Gereç ve Yöntem:
Araştırmamız retrospektif olgu-kontrol çalışması olup çalışmaya 27.03.2020-01.07.2020 tarihleri arasında uyku polikliniğine cihaz kontrolü için başvuran ve en az 1 aylık cihaz kullanım süresi olan 190 OUAS hastası dahil edilmiştir. COVID-19 pandemi-normalleşme süreci ile pandemi öncesindeki ortalama CPAP kullanım süreleri karşılaştırılmıştır.
Bulgular:
Cihaz kullanım sürelerine bakıldığında pandemi öncesi ortalama kullanım süresi 5,3±0,6 saat iken pandemi sonrası ortalama cihaz kullanım süresi 4,5±0,9 saatti. Elli dört hastanın cihaz kullanım süresi pandemi öncesi 4 saatin üzerindeyken, pandemi sonrası 4 saatin altına düşmüştü. Yeterli cihaz kullanım süresi olan hastalarla yetersiz cihaz kullanım süresi olan hastalar karşılaştırıldığında, aralarında insomni, anksiyete ve sirkadyen ritim bozukluğu açısından anlamlı fark olduğu görüldü.
Sonuç:
OUAS hastalarına COVID-19 pandemi döneminde insomni, sirkadyen ritim bozukluğu, kabus bozukluğu gibi uyku bozuklukları eklenmiştir. Eklenen bu uyku bozukluklarının, OUAS hastalarının cihaz uyumunu etkilediği gözlenmiştir.
References
1
Xiao H, Zhang Y, Kong D, Li S, Yang N. Social Capital and sleep quality in individuals who self-isolated for 14 days during the coronavirus disease 2019 (COVID-19) outbreak in January 2020 in China. Med Sci Monit 2020;26:e923921.
2
Xue Z, Lin L, Zhang S, Gong J, Liu J, Lu J. Sleep problems and medical isolation during the SARS-CoV-2 outbreak. Sleep Med 2020;70:112-5.
3
Wu KK, Chan SK, Ma TM. Posttraumatic stress, anxiety, and depression in survivors of severe acute respiratory syndrome (SARS). J Trauma Stress 2005;18:39-42.
4
Altena E, Baglioni C, Espie CA, Ellis J, Gavriloff D, Holzinger B, Schlarb A, Frase L, Jernelöv S, Riemann D. Dealing with sleep problems during home confinement due to the COVID-19 outbreak: Practical recommendations from a task force of the European CBT-I Academy. J Sleep Res 2020;29:e13052.
5
Lavie L. Obstructive sleep apnoea syndrome--an oxidative stress disorder. Sleep Med Rev 2003;7:35-51.
6
Somers VK, White DP, Amin R, Abraham WT, Costa F, Culebras A, Daniels S, Floras JS, Hunt CE, Olson LJ, Pickering TG, Russell R, Woo M, Young T; American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology; American Heart Association Stroke Council; American Heart Association Council on Cardiovascular Nursing; American College of Cardiology Foundation. Sleep apnea and cardiovascular disease: an American Heart Association/american College Of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council On Cardiovascular Nursing. In collaboration with the National Heart, Lung, and Blood Institute National Center on Sleep Disorders Research (National Institutes of Health). Circulation 2008;118:1080-111.
7
McSharry D, Malhotra A. Potential influences of obstructive sleep apnea and obesity on COVID-19 severity. J Clin Sleep Med 2020;16:1645.
8
McNicholas WT. Obstructive sleep apnea and inflammation. Prog Cardiovasc Dis 2009;51:392-9.
9
Chaiard J, Weaver TE. Update on Research and Practices in Major Sleep Disorders: Part I. Obstructive Sleep Apnea Syndrome. J Nurs Scholarsh 2019;51:500-8.
10
Weaver TE, Maislin G, Dinges DF, Bloxham T, George CF, Greenberg H, Kader G, Mahowald M, Younger J, Pack AI. Relationship between hours of CPAP use and achieving normal levels of sleepiness and daily functioning. Sleep 2007;30:711-9.
11
Salepci B, Caglayan B, Kiral N, Parmaksiz ET, Comert SS, Sarac G, Fidan A, Gungor GA. CPAP adherence of patients with obstructive sleep apnea. Respir Care 2013;58:1467-73.
12
Weaver TE, Grunstein RR. Adherence to continuous positive airway pressure therapy: the challenge to effective treatment. Proc Am Thorac Soc 2008;5:173-8.
13
Means MK, Ulmer CS, Edinger JD. Ethnic differences in continuous positive airway pressure (CPAP) adherence in veterans with and without psychiatric disorders. Behav Sleep Med 2010;8:260-73.
14
Sateia MJ. Update on sleep and psychiatric disorders. Chest 2009;135:1370-9.
15
Kjelsberg FN, Ruud EA, Stavem K. Predictors of symptoms of anxiety and depression in obstructive sleep apnea. Sleep Med 2005;6:341-6.
16
Krakow B, Melendrez D, Pedersen B, Johnston L, Hollifield M, Germain A, Koss M, Warner TD, Schrader R. Complex insomnia: insomnia and sleep-disordered breathing in a consecutive series of crime victims with nightmares and PTSD. Biol Psychiatry 2001;49:948-53.
17
Baker JG, Sovani M. Case for continuing community NIV and CPAP during the COVID-19 epidemic. Thorax 2020;75:368. doi: 10.1136/thoraxjnl-2020-214913
18
Acar HV, Kaya A, Genç F, Erdem M, Ceyhan A, Özgen F, Dikmen B. Can Berlin Questionnaire be used as a screening test for Obstructive Sleep Apnea? JARSS 2013;21:99-105.
19
Yazici Güleç M, Güleç H, Simşek G, Turhan M, Aydin Sünbül E. Psychometric properties of the Turkish version of the Patient Health Questionnaire-Somatic, Anxiety, and Depressive Symptoms. Compr Psychiatry 2012;53:623-9.
20
Bhatraju PK, Ghassemieh BJ, Nichols M, Kim R, Jerome KR, Nalla AK, Greninger AL, Pipavath S, Wurfel MM, Evans L, Kritek PA, West TE, Luks A, Gerbino A, Dale CR, Goldman JD, O'Mahony S, Mikacenic C. Covid-19 in Critically Ill Patients in the Seattle Region-Case Series. N Engl J Med 2020;382:2012-22.
21
Liu PP, Blet A, Smyth D, Li H. The science underlying COVID-19: implications for the cardiovascular system. Circulation 2020;142:68-78.
22
Karnatovskaia LV, Lee AS, Bender SP, Talmor D, Festic E; US Critical Illness and Injury Trials Group: Lung Injury Prevention Study Investigators (USCIITG–LIPS). Obstructive sleep apnea, obesity, and the development of acute respiratory distress syndrome. J Clin Sleep Med 2014;10:657-62.
23
Kribbs NB, Pack AI, Kline LR, Smith PL, Schwartz AR, Schubert NM, Redline S, Henry JN, Getsy JE, Dinges DF. Objective measurement of patterns of nasal CPAP use by patients with obstructive sleep apnea. Am Rev Respir Dis 1993;147:887-95.
24
Weaver TE, Sawyer AM. Adherence to continuous positive airway pressure treatment for obstructive sleep apnoea: implications for future interventions. Indian J Med Res 2010;131:245-58.
25
Collen JF, Lettieri CJ, Hoffman M. The impact of posttraumatic stress disorder on CPAP adherence in patients with obstructive sleep apnea. J Clin Sleep Med 2012;8:667-72.
26
Attias D, Pepin JL, Pathak A. Impact of COVID-19 lockdown on adherence to continuous positive airway pressure (CPAP) by obstructive sleep apnoea patients. Eur Respir J 2020;56:2001607. doi: 10.1183/13993003.01607-202
27
Batool-Anwar S, Omobomi OS, Quan SF. Impact of the novel coronavirus disease on treatment adherence and sleep duration in patients with obstructive sleep apnea treated with positive airway pressure. J Clin Sleep Med 2020;16:1917-20.
28
Wang C, Pan R, Wan X, Tan Y, Xu L, Ho CS, Ho RC. Immediate psychological responses and associated factors during the initial stage of the 2019 Coronavirus Disease (COVID-19) epidemic among the general population in China. Int J Environ Res Publ Health 2020;17:1729. doi: 10.3390/ijerph17051729
29
Lai J, Ma S, Wang Y, Cai Z, Hu J, Wei N, Wu J, Du H, Chen T, Li R, Tan H, Kang L, Yao L, Huang M, Wang H, Wang G, Liu Z, Hu S. Factors associated with mental health outcomes among health care workers exposed to Coronavirus Disease 2019. JAMA Netw Open 2020;3:e203976. doi: 10.1001/jamanetworkopen.2020.3976
